iothalamate sodium

iothalamate sodium (CAS No.: 1225-20-3) is a synthetic small molecule classified as an organic iodinated contrast reagent and sodium salt form of iothalamic acid, primarily positioned in biomedical research as a tool compound for renal function assessment workflows, imaging method development, and analytical assay calibration rather than as a direct modulator of canonical drug target classes; based on available literature context, its functional background is associated with extracellular distribution and renal handling characteristics that support tracer like behavior in experimental systems, with no well established high affinity receptor or enzyme target and no defined pathway specific agonist or antagonist signaling profile, so mechanistic interpretation is generally centered on physicochemical partitioning, filtration associated disposition, and measurable clearance kinetics in biological matrices; correspondingly, standardized in vitro potency metrics such as IC50, EC50, or MIC are not typically reported for this compound in the manner used for targeted inhibitors, and activity discussions are more appropriately framed through detection sensitivity, transport related behavior, and concentration dependent analytical readouts that are often evaluated from low micromolar to millimolar working ranges depending on assay platform and matrix complexity; in life sciences and drug discovery settings, iothalamate sodium is commonly referenced for use in method validation studies, permeability and excretion oriented experimental designs, comparative tracer studies in cell based transport investigations, and preclinical animal pharmacokinetic or renal physiology models where concentrations or doses used in experiments typically depend on specific experimental designs and research objectives, with study outcomes interpreted alongside assay format, sampling schedule, and instrument based quantification parameters.